Medicare Enrolled
Dr. Jamal Hammoud, M.D.
Endocrinology · Flint, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hammoud from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hammoud?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hammoud
Dr. Jamal Hammoud is an endocrinology specialist in Flint, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hammoud performed 4,672 Medicare services across 2,679 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hammoud received a total of $457,657 from 70 pharmaceutical and/or device companies across 1875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hammoud is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in MI
$457,657 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,672
Medicare services
Top 4% in MI for endocrinology
2,679
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~246 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
824 | $88 | $163 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
743 | $62 | $112 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
667 | $38 | $68 |
| Hemoglobin a1c level, by device for home use | 620 | $9 | $18 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
612 | $4 | $10 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
352 | $24 | $72 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
183 | $100 | $305 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
154 | $60 | $111 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
147 | $78 | $235 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
129 | $111 | $232 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
51 | $103 | $225 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
50 | $30 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
47 | $29 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $9 | $25 |
| Ultrasound-guided fine needle aspiration biopsy, each additional growth This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session. |
28 | $46 | $100 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
15 | $5 | $10 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
11 | $35 | $77 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$457,657
Total received (2018-2024)
Avg $65,380/year across 7 years
Top 3% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,875
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$444,251 (97.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,406 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$46,341
2023
$58,909
2022
$42,653
2021
$30,597
2020
$57,093
2019
$109,095
2018
$112,969
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$38,565
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,455
Amgen Inc.
$336
Corcept Therapeutics
$263
Abbott Laboratories
$222
Xeris Pharmaceuticals, Inc.
$197
Novo Nordisk Inc
$196
ABBVIE INC.
$119
SANOFI-AVENTIS U.S. LLC
$102
Tandem Diabetes Care, Inc.
$97
Neurocrine Biosciences, Inc.
$93
Medtronic, Inc.
$88
Amneal Pharmaceuticals LLC
$81
Insulet Corporation
$79
CeQur Corporation
$61
Alexion Pharmaceuticals, Inc.
$52
RECORDATI_RARE_DISEASES_INC.
$52
Dexcom, Inc.
$43
Antares Pharma, Inc.
$42
IBSA Pharma Inc.
$30
Novartis Pharmaceuticals Corporation
$28
Amphastar Pharmaceuticals, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Radius Health, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$19
Verity Pharmaceuticals Inc.
$18
AstraZeneca Pharmaceuticals LP
$16
Seqirus USA Inc
$14
BETA BIONICS, INC.
$11
Top 3 companies account for 95.7% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$222,583
AstraZeneca Pharmaceuticals LP
$50,921
Boehringer Ingelheim Pharmaceuticals, Inc.
$48,420
SANOFI-AVENTIS U.S. LLC
$36,818
Novo Nordisk Inc
$35,096
Janssen Pharmaceuticals, Inc
$23,001
Merck Sharp & Dohme Corporation
$20,618
Medtronic MiniMed, Inc.
$8,743
Corcept Therapeutics
$1,512
Boehringer Ingelheim International GmbH
$1,213
Amgen Inc.
$1,129
Xeris Pharmaceuticals, Inc.
$879
Abbott Laboratories
$804
Dexcom, Inc.
$557
Antares Pharma, Inc.
$412
Medtronic, Inc.
$378
DEXCOM, INC.
$331
Insulet Corporation
$312
ABBVIE INC.
$308
Amneal Pharmaceuticals LLC
$261
Radius Health, Inc.
$233
IBSA Pharma Inc.
$201
AbbVie Inc.
$198
Shire North American Group Inc
$198
Horizon Therapeutics plc
$195
Bayer Healthcare Pharmaceuticals Inc.
$161
Mannkind Corporation
$151
Tandem Diabetes Care, Inc.
$146
RECORDATI_RARE_DISEASES_INC.
$142
PFIZER INC.
$113
Alexion Pharmaceuticals, Inc.
$112
MannKind Corporation
$111
Ultragenyx Pharmaceutical Inc.
$97
Neurocrine Biosciences, Inc.
$93
AbbVie, Inc.
$84
Takeda Pharmaceuticals U.S.A., Inc.
$75
Valeritas, Inc.
$71
CeQur Corporation
$70
Nevro Corp.
$70
Alvogen Inc
$68
Amarin Pharma Inc.
$61
Becton, Dickinson and Company
$59
Bayer HealthCare Pharmaceuticals Inc.
$50
Embecta Corp.
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$39
EUSA Pharma (US) LLC
$38
GENZYME CORPORATION
$32
Clarus Therapeutics Inc.
$29
Ascendis Pharma Inc
$28
Novartis Pharmaceuticals Corporation
$28
Aytu BioScience, Inc
$28
LifeScan, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$22
Ascendis Pharma, Inc.
$22
LIFESCAN, INC.
$21
Amphastar Pharmaceuticals, Inc.
$21
Amryt Pharma Holdings Ltd
$20
Supernus Pharmaceuticals, Inc.
$20
Verity Pharmaceuticals Inc.
$18
VIVUS, Inc.
$18
Acella Pharmaceuticals, LLC
$17
Gilead Sciences, Inc.
$16
Acerus Pharmaceuticals Corporation
$16
RGH ENTERPRISES LLC
$16
Nestle HealthCare Nutrition Inc.
$15
EISAI INC.
$15
Currax Pharmaceuticals LLC
$15
Seqirus USA Inc
$14
BETA BIONICS, INC.
$11
GRT US Holding, Inc.
$11
Top 3 companies account for 70.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · Alere Afinion · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · CONTRAVE · CRENESSITY · CRYSVITA · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flucelvax · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kanuma · Kerendia · Korlym · LEQVIO · LICART · LINZESS · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NP Thyroid · Natesto · OTREXUP · Omnia · Omnipod · OneTouch · Otrexup · Ozempic · Prolia · QSYMIA · Qutenza · RECORLEV · RETEVMO · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Senza · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · THYROGEN · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XIGDUO · XYOSTED · ZENPEP · ZEPBOUND · iLet Bionic Pancreas · iPro2 · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for endocrinology in MI.
Geographic Context
Endocrinologists within 10 mi
6
Per 100K population
1.5
County median income
$60,673
Nearest hospital
MCLAREN FLINT
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hammoud is a clinical cardiology specialist, with above-average Medicare volume (top 4% in MI), with speaking/promotional industry engagement in the top 3% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hammoud experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hammoud performed 824 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hammoud receive payments from pharmaceutical companies?
Yes. Dr. Hammoud received a total of $457,657 from 70 companies across 1,875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hammoud's costs compare to other endocrinologists in Flint?
Dr. Hammoud's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hammoud) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Flint
Browse endocrinologists in Flint ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology